Graphene quantum dot-crafted nanocomposites: shaping the future landscape of biomedical advances

Graphene quantum dots (GQDs) are a newly developed class of material, known as zero-dimensional nanomaterials, with characteristics derived from both carbon dots (CDs) and graphene. GQDs exhibit several ideal properties, including the potential to absorb incident energy, high water solubility, tunable photoluminescence, good stability, high drug-loading capacity, and notable biocompatibility, which make them powerful tools for various applications in the field of biomedicine. Additionally, GQDs can be incorporated with additional materials to develop nanocomposites with exceptional qualities and enriched functionalities. Inspired by the intriguing scientific discoveries and substantial contributions of GQDs to the field of biomedicine, we present a broad overview of recent advancements in GQDs-based nanocomposites for biomedical applications. The review first outlines the latest synthesis and classification of GQDs nanocomposite and enables their use in advanced composite materials for biomedicine. Furthermore, the systematic study of the biomedical applications for GQDs-based nanocomposites of drug delivery, biosensing, photothermal, photodynamic and combination therapies are emphasized. Finally, possibilities, challenges, and paths are highlighted to encourage additional research, which will lead to new therapeutics and global healthcare improvements.

A comparative multi-level toxicity assessment of carbon-based Gd-free dots and Gd-doped nanohybrids from coffee waste: hematology, biochemistry, histopathology and neurobiology study

Here, a comparative toxicity assessment of precursor carbon dots from coffee waste (cofCDs) obtained using green chemistry principles and Gd-doped nanohybrids (cofNHs) was performed using hematological, biochemical, histopathological assays in vivo (CD1 mice, intraperitoneal administration, 14 days), and neurochemical approach in vitro (rat cortex nerve terminals, synaptosomes). Serum biochemistry data revealed similar changes in cofCDs and cofNHs-treated groups, i.e. no changes in liver enzymes' activities and creatinine, but decreased urea and total protein values. Hematology data demonstrated increased lymphocytes and concomitantly decreased granulocytes in both groups, which could evidence inflammatory processes in the organism and was confirmed by liver histopathology; decreased red blood cell-associated parameters and platelet count, and increased mean platelet volume, which might indicate concerns with platelet maturation and was confirmed by spleen histopathology. So, relative safety of both cofCDs and cofNHs for kidney, liver and spleen was shown, whereas there were concerns about platelet maturation and erythropoiesis. In acute neurotoxicity study, cofCDs and cofNHs (0.01 mg/ml) did not affect the extracellular level of L-[14C]glutamate and [3H]GABA in nerve terminal preparations. Therefore, cofNHs demonstrated minimal changes in serum biochemistry and hematology assays, had no acute neurotoxicity signs, and can be considered as perspective biocompatible non-toxic theragnostic agent.

Size Fractionation of Fluorescent Graphene Quantum Dots Using a Cross-Flow Membrane Filtration System

Graphene quantum dots (GQDs) have received great attention as optical agents because of their low toxicity, stable photoluminescence (PL) in moderate pH solutions, and size-dependent optical properties. Although many synthetic routes have been proposed for producing GQD solutions, the broad size distribution in GQD solutions limits its use as an efficient optical agent. Here, we present a straightforward method for size fractionation of GQDs dispersed in water using a cross-flow filtration system and a track-etched membrane with cylindrical uniform nanopores. The GQD aqueous suspension, which primarily contained blue-emitting GQDs (B-GQDs) and green-emitting GQDs (G-GQDs), was introduced to the membrane in tangential flow and was fractionated with a constant permeate flow of about 800 L m-2 h-1 bar-1. After filtration, we observed a clear blue PL spectrum from the permeate side, which can be attributed to selective permeation of relatively small B-GQDs. The process provided a separation factor (B-GQDs/G-GQDs) of 0.74. In the cross-flow filtration system, size-dependent permeation through cylindrical nanochannels was confirmed by simulation. Our results demonstrate a feasible method facilitating size fractionation of two-dimensional nanostructures using a cross-flow membrane filtration system. Since membrane filtration is simple, cost-effective, and scalable, our approach can be applied to prepare a large amount of size-controlled GQDs required for high performance opto-electronics and bio-imaging applications.